Top Markets
Coin of the day
N4 Pharma Plc N4 Pharma Plc

N4 Pharma Plc

N4P
Rank in Stocks #35960
N4 Pharma Plc is a specialized pharmaceutical company dedicated to creating... N4 Pharma Plc is a specialized pharmaceutical company dedicated to creating advanced silica nanoparticle delivery platforms for pharmaceutical and biotechnology organizations throughout the United Kingdom. A core product is Nuvec, a non-viral adjuvant delivery system specifically designed for use in vaccine development and cancer therapies. Founded in 1979, the company is headquartered in London, UK.
Share Price
$0.00918474
Last synced: 2026-04-13
Market Cap
$3.13M
Change (1 day)
50.00%
Change (1 year)
-2.45%
Country
GB
Trade N4 Pharma Plc (N4P)

Category

P/B ratio for N4 Pharma Plc (N4P)
P/B ratio as of September 2026 TTM: 2.50
According to N4 Pharma Plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.50. At the end of 2023 the company had a P/B ratio of 1.83.
P/B ratio history for N4 Pharma Plc from 2000 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 2.50 -9.55%
2024 2.76 50.71%
2023 1.83 10.86%
2022 1.65 -56.35%
2021 3.78 21.59%
2020 3.11 11.54%
2019 2.79 -70.64%
2018 9.50 84.96%
2017 5.14 135.16%
2016 2.18 449.11%
2015 0.40 -68.85%
2014 1.28 88.45%
2013 0.68 2.99%
2012 0.66 -13.38%
2011 0.76 -54.80%
2010 1.68 35.93%
2009 1.24 -44.36%
2008 2.22 44.89%
2007 1.53 -22.69%
2006 1.98 -76.85%
2005 8.57 76.86%
2004 4.85 -213.33%
2003 -4.28 107.38%
2002 -2.06 217.27%
2001 -0.65 -71.69%
2000 -2.30 0.00%
P/B ratio for similar companies or competitors